HMC Opens Specialised Clinic for Cancer Patients Requiring Intravenous Treatment

Hamad Medical Corporation (HMC) has launched a new specialised clinic at Hamad General Hospital (HGH) to support cancer patients who require repeated intravenous treatments. The clinic provides specialised assessments to determine the most appropriate method of care tailored to each patient's condition and treatment plan.

The clinic brings together oncology and vascular surgery teams from the National Center for Cancer Care and Research (NCCCR) and the Vascular Surgery Department at HGH. This allows for a comprehensive understanding of each patient's needs related to intravenous treatment and facilitates planning and follow-up at every stage of treatment.

According to Dr. Mohammed Salem Al Hassan, Medical Director and CEO of NCCCR and Chairman of Cancer Services at HMC, as reported by the Gulf Times, the clinic aims to address a critical challenge many patients experience during treatment. Many cancer patients require medications and treatments to be administered intravenously repeatedly, but some may experience difficulty establishing and maintaining suitable venous access for treatment.

Brief written by urgent.news from Marhaba Qatar, Gulf Times, The Peninsula Qatar — 3 reports on this story. Machine-written — may contain errors; check the original before relying on it.